Mankind Pharma Limited (MANKIND) — Announcement | 10 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Management to present at three August investor conferences
💡 Investor Takeaway
Investors can expect management updates on business outlook at upcoming conferences.

Mankind Pharma announced its management will attend three investor conferences in August 2026, including Emkay Confluence, Equirus Annual India Conference, and Motilal Oswal Global Investor Conference, to discuss general business outlook without disclosing new price-sensitive information.

📄 View Original Announcement (PDF)

About Mankind Pharma Limited (MANKIND)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹97,467.05 Cr P/E: 47.7 ROE: 12.7% ROCE: 13.9% Div Yield: 0.04%

View full MANKIND stock details →

📡 Get AI alerts when MANKIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANKIND — Free

📊 More MANKIND filings

See all MANKIND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MANKIND files new disclosures

Track MANKIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANKIND — Free

Free account · 2 AI queries/day